Ming-liang Cheng
- Topics
- Liver Disease Diagnosis and Treatment (7 papers)Liver physiology and pathology (3 papers)Gut microbiota and health (3 papers)
- Cited by
- HepatologyPharmacologyEpidemiology
- Partner nations
- ChinaUnited States
In The Last Decade
Ming-liang Cheng
21 papers receiving 382 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 173
- Epidemiology 100
- Hepatology 57
- Pharmacology 41
- Pathology and Forensic Medicine 35
Countries citing papers authored by Ming-liang Cheng
This map shows the geographic impact of Ming-liang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-liang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-liang Cheng more than expected).
Fields of papers citing papers by Ming-liang Cheng
This network shows the impact of papers produced by Ming-liang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-liang Cheng. The network helps show where Ming-liang Cheng may publish in the future.
Co-authorship network of co-authors of Ming-liang Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Ming-liang Cheng. A scholar is included among the top collaborators of Ming-liang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-liang Cheng. Ming-liang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Protective effect of endothelial progenitor cell-derived exosomal microRNA-382-3p on sepsis-induced organ damage and immune suppression in mice. | 11 |
| 3 | 37 | |
| 4 | 2 | |
| 5 | 53 | |
| 6 | 1 | |
| 7 | 27 | |
| 8 | 80 | |
| 9 | 32 | |
| 10 | 62 | |
| 11 | 23 | |
| 12 | 1 | |
| 13 | [The relationship of metallothionein and liver fibrosis]. | 4 |
| 14 | Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis. | 11 |
| 15 | [Differential analysis of associated proteome in hepatic fibrosis tissue]. | 2 |
| 16 | [Research into methylation of p16 gene in the patients suffering from coal-burnt arsenism in Xingren County Guizhou Province]. | 1 |
| 17 | [Expression of PKC in rat hepatic fibrosis and the effect of Dan-shao-hua-xian Capsule on its expression pattern]. | 6 |
| 18 | 12 | |
| 19 | [Changes of collagenase activity in immune hepatic fibrosis following pig's serum injection and therapeutic effect of HanDanGanLe]. | 2 |
| 20 | Effect of total-body irradiation with bone marrow transplantation on toxicity of cisplatin. | 6 |
About Ming-liang Cheng
Ming-liang Cheng is a scholar working on Hepatology, Pharmacology and Nephrology, having authored 22 papers that have together received 386 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Hepatology (57 citations), Pharmacology (41 citations) and Epidemiology (100 citations). Ming-liang Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Zhuo Cheng, Xueke Zhao, Lei Yu, Yaxin Hu, Yongmei Liu, Mao Mu, Chi Chen, Lili Zhu, Yongmei Liu and Lei Yu. Their work appears in journals such as PLoS ONE, Scientific Reports and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.